Australia
Tuberculosis profile
Population  2012 23 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.045 (0.044–0.045) 0.19 (0.19–0.19)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.02 (0.01–0.02)
Prevalence  (includes HIV+TB) 2 (0.86–3.7) 8.8 (3.7–16)
Incidence  (includes HIV+TB) 1.5 (1.3–1.7) 6.5 (5.7–7.4)
Incidence (HIV+TB only) 0.038 (0.033–0.043) 0.17 (0.14–0.19)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 290 (23) Relapse 26 (57)
Smear-negative 330 (26) Treatment after failure 1 (2)
Smear-unknown / not done 78 (6) Treatment after default 0 (0)
Extrapulmonary 498 (40) Other 19 (41)
Other 63 (5)      
Total new 1 259   Total retreatment 46  
           
Other (history unknown) 20        
Total new and relapse 1 285   Total cases notified 1 325  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.3 1.4 1.1
Age < 15 4 28 16
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 77   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 78  
Retreatment 66  
TB/HIV 2012 Number (%)
TB patients with known HIV status 740 (56)
HIV-positive TB patients 8 (1)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.9 (1.1–3) 6.5 (0.79–21)
MDR-TB cases among notified pulmonary
TB cases
14 (8–23) 3 (0–10)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 861 (129%) 31 (67%) 896
Laboratory-confirmed MDR-TB cases 16 2 18
Patients started on MDR-TB treatment     16
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-20 Data: www.who.int/tb/data